Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide

por Fujmoto, Saizo, Fujita, Kazutoshi, Nishimoto, Mitsuhisa, Hamaguchi, Mamoru, Kuwahara, Ken, Hashimoto, Mamoru, Adomi, Shogo, Minami, Takafumi, Nozawa, Masahiro, Yoshimura, Kazuhiro, Uemura, Hirotsugu
Publicado 2022

Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report

por Hashimoto, Mamoru, Minami, Takafumi, Hamaguchi, Mamoru, Fujimoto, Saizo, Takahashi, Tomoki, Kikuchi, Takashi, Adomi, Shogo, Banno, Eri, Ohzeki, Takayuki, Shimizu, Nobutaka, Mori, Yasunori, Nozawa, Masahiro, Nose, Kazuhiro, Yoshimura, Kazuhiro, Uemura, Hirotsugu
Publicado 2019

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patient...

por Hashimoto, Mamoru, Fujita, Kazutoshi, Nakayama, Takahito, Fujimoto, Saizo, Hamaguchi, Mamoru, Nishimoto, Mitsuhisa, Kikuchi, Takashi, Adomi, Shogo, Banno, Eri, De Velasco, Marco A., Saito, Yoshitaka, Shimizu, Nobutaka, Mori, Yasunori, Minami, Takafumi, Nozawa, Masahiro, Nose, Kazuhiro, Yoshimura, Kazuhiro, Uemura, Hirotsugu
Publicado 2021